1:18 PM
 | 
Jan 09, 2019
 |  BC Extra  |  Company News

Management tracks: Tak joins Flagship, Evercore taps Mehrotra

Paul-Peter Tak has stepped down from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) to join Flagship Pioneering as a venture partner. He was GSK's SVP of R&D, chief immunology officer and development lead.

Evercore ISI hired Ravi Mehrotra as senior managing director for biotechnology equity research. Mehrotra was a partner at MTS Health Partners.

J.P. Morgan hired Ling Zhang as head of healthcare and technology for global investment banking in China. He was COO at BGI Genomics Co. Ltd. (SZSE:300676).

Abeona Therapeutics Inc. (NASDAQ:ABEO) promoted Christine Silverstein to CFO and hired Edward Carr as chief accounting officer. Silverstein, who fills a position that had been vacant since 2017, was the rare genetic disease company's SVP of finance and investor relations. Carr, who succeeds Stephen Thompson following his December retirement, was VP and assistant controller at Coty Inc. (NYSE:COTY).

Flagship Pioneering spinout Cygnal Therapeutics (Cambridge, Mass.) hired Pearl Huang as CEO. Cygnal is developing products against traditionally neuronal targets to treat cancer and other diseases, including autoimmune and inflammatory disorders. Huang was SVP and global head of therapeutic modalities at Roche (SIX:ROG; OTCQX:RHHBY).

Rare disease company Therachon AG (Basel, Switzerland) hired Claudia D'Augusta as its first CFO. D'Augusta was CFO at TiGenix N.V., which Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) acquired. Therachon completed a $60 million mezzanine round in August 2018 (see "Novo Holdings Leads Therachon's $60M Round").

TAE Life Sciences (Foothill Ranch, Calif.) named Robert Hill COO. The biotech spun out of energy company TAE Technologies Inc. (Foothill Ranch, Calif.) in March 2018 to develop a radiation therapy for cancer. Hill was SVP of corporate development at Accuray Inc. (NASDAQ:ARAY) (see "Energy Firm Spins Out Biotech with $40M Series A").

Immunotherapy play Cellenkos Inc. (Houston, Texas) hired Elizabeth Read as CTO. She was CTO at Adicet Bio Inc. (Menlo Park, Calif.).

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

Purchase this article for limited one-time distribution and website posting

$750 USD